Abstract

Similar articles

• Genetic engineering in Streptomyces roseosporus to produce hybrid lipopeptide antibiotics.

  Miao V, Coëffet-Le Gal MF, Nguyen K, Brian P, Penn J, Whiting A, Steele J, Kau D, Martin S, Ford R, Gibson T, Bouchard M, Wrigley SK, Baltz RH.Miao V, et al.Chem Biol. 2006 Mar;13(3):269-76. doi: 10.1016/j.chembiol.2005.12.012.Chem Biol. 2006.PMID:16638532
• Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.

  Steenbergen JN, Alder J, Thorne GM, Tally FP.Steenbergen JN, et al.J Antimicrob Chemother. 2005 Mar;55(3):283-8. doi: 10.1093/jac/dkh546. Epub 2005 Feb 10.J Antimicrob Chemother. 2005.PMID:15705644Review.
• Chemoenzymatic design of acidic lipopeptide hybrids: new insights into the structure-activity relationship of daptomycin and A54145.

  Kopp F, Grünewald J, Mahlert C, Marahiel MA.Kopp F, et al.Biochemistry. 2006 Sep 5;45(35):10474-81. doi: 10.1021/bi0609422.Biochemistry. 2006.PMID:16939199
• The structural diversity of acidic lipopeptide antibiotics.

  Strieker M, Marahiel MA.Strieker M, et al.Chembiochem. 2009 Mar 2;10(4):607-16. doi: 10.1002/cbic.200800546.Chembiochem. 2009.PMID:19156787Review.
• Synthesis and derivatization of daptomycin: a chemoenzymatic route to acidic lipopeptide antibiotics.

  Grünewald J, Sieber SA, Mahlert C, Linne U, Marahiel MA.Grünewald J, et al.J Am Chem Soc. 2004 Dec 29;126(51):17025-31. doi: 10.1021/ja045455t.J Am Chem Soc. 2004.PMID:15612741

Cited by

• The isotridecanyl side chain of plusbacin-A3 is essential for the transglycosylase inhibition of peptidoglycan biosynthesis.

  Kim SJ, Singh M, Wohlrab A, Yu TY, Patti GJ, O'Connor RD, VanNieuwenhze M, Schaefer J.Kim SJ, et al.Biochemistry. 2013 Mar 19;52(11):1973-9. doi: 10.1021/bi4000222. Epub 2013 Mar 5.Biochemistry. 2013.PMID:23421534Free PMC article.
• Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibiotics.

  Okano A, Nakayama A, Wu K, Lindsey EA, Schammel AW, Feng Y, Collins KC, Boger DL.Okano A, et al.J Am Chem Soc. 2015 Mar 18;137(10):3693-704. doi: 10.1021/jacs.5b01008. Epub 2015 Mar 9.J Am Chem Soc. 2015.PMID:25750995Free PMC article.
• Antibiotics and Antibiotic Resistance-Mur Ligases as an Antibacterial Target.

  Hervin V, Roy V, Agrofoglio LA.Hervin V, et al.Molecules. 2023 Dec 13;28(24):8076. doi: 10.3390/molecules28248076.Molecules. 2023.PMID:38138566Free PMC article.Review.
• Back to the future: a new 'old' lead for tuberculosis.

  Wright GD.Wright GD.EMBO Mol Med. 2012 Oct;4(10):1029-31. doi: 10.1002/emmm.201201811. Epub 2012 Sep 17.EMBO Mol Med. 2012.PMID:22987753Free PMC article.No abstract available.
• Marine Biosurfactants: Biosynthesis, Structural Diversity and Biotechnological Applications.

  Kubicki S, Bollinger A, Katzke N, Jaeger KE, Loeschcke A, Thies S.Kubicki S, et al.Mar Drugs. 2019 Jul 9;17(7):408. doi: 10.3390/md17070408.Mar Drugs. 2019.PMID:31323998Free PMC article.Review.

Publication types

• Research Support, Non-U.S. Gov't
• Review

MeSH terms

• Anti-Bacterial Agents / chemistry
• Anti-Bacterial Agents / pharmacology
• Daptomycin* / chemistry
• Daptomycin* / pharmacology
• Gram-Positive Bacterial Infections / drug therapy*
• Lipoproteins* / chemistry
• Lipoproteins* / pharmacology
• Microbial Sensitivity Tests
• Molecular Structure

Substances

• Anti-Bacterial Agents
• Lipoproteins
• Daptomycin

Related information

• MedGen
• PubChem Compound
• PubChem Compound (MeSH Keyword)
• PubChem Substance

LinkOut - more resources

• Full Text Sources

  • Royal Society of Chemistry

• Other Literature Sources

  • The Lens - Patent Citations Database